IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pfizer Inc

Portfolio Profile

CIK: 0000078003 | New York, NY

Investment Profile

Style

Deep Value

Turnover

Very Low

Orientation

Concentrated long-term
$170.4M
AUM
17
Positions
95.78%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Allogene Therapeutics Inc(ALLO)22,032,040$46.9M27.55%
2Celcuity Inc(CELC)295,652$29.6M17.35%
3Arvinas Inc(ARVN)3,457,815$27.7M16.24%
4Pyxis Oncology Inc(PYXS)7,032,770$19.5M11.43%
5Wave Life Sciences LTD(WVE)1,875,000$10.9M6.42%
6

Sector Allocation

Latest filing, equity positions only

Healthcare91.88% · $156.5M
Unclassified8.12% · $13.8M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare87.95%91.88%+3.93%
Unclassified12.05%8.12%-3.93%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$2.6B | 26 pos.
$500.8M | 24 pos.
$576.2M | 24 pos.
$437.5M | 24 pos.
$236.5M | 21 pos.
$238.8M | 21 pos.
Biohaven LTD(BHVN)
505,645
$8.0M
4.70%
7Caribou Biosciences Inc(CRBU)4,690,431$7.9M4.63%
8Spero Therapeutics Inc(SPRO)2,362,348$5.3M3.13%
9Zentalis Pharmaceuticals Inc(ZNTL)953,834$3.9M2.26%
10Oric Pharmaceuticals Inc(ORIC)372,904$3.6M2.09%
Cap SizePrev %Curr %Change
Small Cap59.97%46.49%-13.48%
Micro Cap13.07%23.35%+10.28%
Mid Cap14.9%22.04%+7.14%
Unclassified12.05%8.12%-3.93%
$170.4M | 20 pos.
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

0
New
1
Closed
0
Increased
3
Decreased
14
Unchanged